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ABSTRACT
5-fluorouracil (5-FU) is a widely used chemotherapeutic drug in colorectal cancer. 
Previous studies showed that 5-FU modulates RNA metabolism and mRNA expression. 
In addition, it has been reported that 5-FU incorporates into the RNAs constituting the 
translational machinery and that 5-FU affects the amount of some mRNAs associated 
with ribosomes. However, the impact of 5-FU on translational regulation remains unclear. 
Using translatome profiling, we report that a clinically relevant dose of 5-FU induces 
a translational reprogramming in colorectal cancer cell lines. Comparison of mRNA 
distribution between polysomal and non-polysomal fractions in response to 5-FU treatment 
using microarray quantification identified 313 genes whose translation was selectively 
regulated. These regulations were mostly stimulatory (91%). Among these genes, we 
showed that 5-FU increases the mRNA translation of HIVEP2, which encodes a transcription 
factor whose translation in normal condition is known to be inhibited by mir-155. In 
response to 5-FU, the expression of mir-155 decreases thus stimulating the translation of 
HIVEP2 mRNA. Interestingly, the 5-FU-induced increase in specific mRNA translation was 
associated with reduction of global protein synthesis. Altogether, these findings indicate 
that 5-FU promotes a translational reprogramming leading to the increased translation of a 
subset of mRNAs that involves at least for some of them, miRNA-dependent mechanisms. 
This study supports a still poorly evaluated role of translational control in drug response.
INTRODUCTION
Translational control regulating one of the last steps of 
gene expression, plays a key role in tumor development [1, 
2]. By finely regulating the synthesis of a specific subset of 
proteins, translational control contributes to tumor initiation, 
invasion and metastasis. In contrast, the role of translational 
control in anti-cancer drug response is just starting to emerge 
and large-scale analysis of the translatome has been carried 
out for only a few anti-cancer drugs [3-6].
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Among the drugs commonly used in chemotherapy, 
5-fluorouracil (5-FU) is an anti-metabolite widely given in 
first-line of treatment in many types of solid cancers. For a 
long time, the 5-FU-induced cytotoxic effects were thought 
to result exclusively from its impact on DNA metabolism, in 
particular from 5-FU-induced inhibition of DNA synthesis and 
induction of DNA damage [7]. However, several evidences 
indicate that the cytotoxic effect of 5-FU also results from 
its capacity to alter RNA metabolism and mRNA expression 
[7]. 5-FU can be incorporated into all species of RNAs after 
its conversion into fluorouridine triphosphate (FUTP) and 
media complementation with uridine, which allowed recovery 
of normal RNA metabolism, compensate most of the 5-FU-
induced cytotoxic effects [8-11]. Furthermore, exposure to 
5-FU promotes a profound transcriptional reprogramming 
leading to modification of mRNA and miRNAs expression 
profiles that contributes in modifying cell fate [12-14].
Although 5-FU directly alters RNA metabolism and 
mRNA expression, the impact of 5-FU on translation has yet 
been poorly characterized. Several evidences indicate that 
5-FU could alter translation. It has been shown that 5-FU 
affects processing and functions of two components of the 
translational machinery, ribosomal RNA (rRNA) and transfer 
RNA (tRNA) [15-18]. Moreover, genome-wide screening in 
yeast revealed that rRNA and tRNA processing factors mediate 
a part of 5-FU cytotoxicity [19-22]. Finally, two large-scale 
studies showed that 5-FU could regulate the translational 
output of a set of mRNAs [23, 24]. For some of these mRNAs, 
their global expression levels were not strongly affected by 
5-FU, while their abundance in the polysomal fractions (i.e. 
ribosome-bound mRNAs) was modulated. Although these data 
raised the possibility that their translational efficiency might be 
regulated by 5-FU, it was not clearly addressed in these studies. 
Therefore, the regulation of translational efficiency by 5-FU 
has not been determined on a large-scale, and the molecular 
mechanisms mediating such regulations were not determined.
In the present study, to investigate whether 
treatment with a clinically relevant dose of 5-FU affects 
the translational efficiency of specific mRNAs, we 
performed a genome-wide analysis of the translatome by 
comparing the distribution of mRNAs within polysomes 
(actively translated RNAs) and non-polysomes (free non-
translated and poorly translated mRNAs) in a panel of 
colorectal cancer cells treated by 5-FU. This approach 
showed that 5-FU induces a translational reprogramming, 
characterized by an increased translational efficiency of 
specific genes that was mediated, at least in part, through 
5-FU-modulation of miRNA expression.
RESULTS
Cells remain viable and metabolically active in 
response to 10 µM of 5-FU
We first optimized 5-FU treatment condition to harvest 
HCT-116 colorectal cancer cells that retain cell viability 
and metabolic activity. Cell response to increasing 
concentrations of 5-FU was monitored in real-time for 
72 hrs using electrical impedance-derived technology 
(Figure 1A) [25]. Compared to non-treated cells, two 
different kinetics of 5-FU response were observed 
depending on the dose. At 100 μM and 500 µM, 5-FU 
induced a decrease of impedance signal from 24 hrs post-
treatment. At these doses, a significant reduction of total 
cell number and an increase in the percentage of dead 
cells were also observed (Figures 1B-1C). In response 
to 10 μM of 5-FU, the decrease of impedance signal was 
delayed by 24 hrs (Figure 1A). In this condition, the total 
cell number remained stable between 24 and 48 hrs post-
treatment and no significant change in the percentage of 
dead cell was observed (Figures 1B-1C), while the 5-FU 
treatment was effective as soon as after 4 hrs of exposure 
as shown by the increased expression of the stress sensor 
p53 (Supplementary Figure 1A). These data showed that, 
compared to 100 µM and 500 µM, cytotoxicity in response 
to 10 μM of 5-FU was delayed, as cells were still viable at 
24 and 48 hrs post-treatment.
To determine whether HCT-116 cells treated with 
different doses of 5-FU retained a metabolic activity at 24 
hrs and 48 hrs, we performed MTS assays (Figure 1D). 
Cells treated with 100 μM and 500 μM of 5-FU showed a 
strong decrease of their metabolic activity. In contrast, a 
slight but significant increase in metabolic activity 24 hrs 
post-treatment was observed in 10 µM 5-FU treated cells, 
followed by a decrease back to their initial level by 48 
hrs of treatment. Altogether, these data indicated that cells 
exposed to 10 μM of 5-FU remained viable and retained 
metabolic activity even at 48 hrs post-treatment.
5-FU reduces global protein synthesis
Before analyzing specific changes in translation that 
occur in response to 5-FU in viable cells retaining metabolic 
activity, we determined whether HCT-116 cells treated with 
10 µM of 5-FU maintained their capacity to synthesize 
proteins. Using 35S pulse-labeling experiments, we 
compared levels of global protein synthesis between non-
treated cells (NT) and cells exposed to 10 µM of 5-FU for 
24 hrs (Figure 2A). Cycloheximide (CHX) treatment was 
used as a positive control of complete inhibition of global 
protein synthesis. 35S quantification revealed a decrease of 
about 20% of the global level of protein synthesis in treated 
cells compared to non-treated cells (Figures 2A-2B).
We then compared polysome profiles through 
sucrose gradients from non-treated cells and cells 
treated with 10 μM of 5-FU (Figures 2C-2D). Typical 
polysome profiles were obtained for non-treated and 
treated HCT-116 cells using both real-time absorbance 
detection and RNA visualization on agarose gel. The 
total quantity of 40S, 60S subunits, 80S monosomes 
and polysomes for a given amount of cytosolic extract 
was decreased in 5-FU treated cells. In particular, the 
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60S subunits and the monosomes 80S were drastically 
decreased. Using 32P pulse labeling, we confirmed that 
levels of ribosome decreased in 5-FU-treated cells 
compared to non-treated ones, and that 60S and 80S 
are more prone to reduction than 40S (data not shown). 
This decrease in ribosomes quantity is concordant 
with the reduction of ribosome production previously 
described in response to 5-FU [15, 18, 21]. Reduction in 
ribosome production in response to 5-FU was probably 
partly responsible for the decrease of global protein 
synthesis (Figures 2A-2B). These data showed that 
HCT-116 cells exposed to 10 µM of 5-FU for 24 hrs 
retained the capability to synthesize proteins although 
the global protein synthesis rate was reduced.
5-FU promotes association of a subset of mRNAs 
with polysomes
Because global protein synthesis was slightly decreased 
but still highly effective in response to 10 µM of 5-FU for 24 
hrs in HCT-116 cells, we investigated whether this treatment 
induced a modulation of the translational efficiency of some 
specific mRNAs using translatome profiling, a widely used 
method [26]. We used a three-steps process that allows 
determining the variation of distribution of each cytosolic 
Figure 1: Effects of 5-FU treatment on HCT-116 cell biology. (A) Real-time monitoring of HCT-116 cells in response to 5-FU 
treatment. Cells were treated 24 hrs post-seeding with increasing concentrations of 5-FU. The cell index (CI) relating change in cell 
number and attachment was monitored every 15 min for 72 hrs using the xCELLigence System and normalized to the starting time of 
5-FU treatment. Delay in cytotoxicity is induced by 10 µM of 5-FU compared to 100 µM or 500 µM. This graph represents mean values 
of a quadruplicate, from one representative experiment. Experiments were repeated three times. Error bars indicate the standard deviation 
(SD). (B-C) Viability of HCT-116 cells in response to 5-FU treatment. Total cell numbers (B) and percentage of dead and viable cells (C) 
in response to 5-FU were quantified using trypan blue staining method at different time points. Compared to non-treated cells, exposition 
to 100 μM and 500 μM of 5-FU promotes drastic decrease in total cell numbers and increase in cell death, while exposition to 10 μM of 
5-FU showed no impact on cell death. (D) Metabolic activity of HCT-116 cells in response to 5-FU treatment. Cells were treated with 
increasing concentrations of 5-FU and metabolic activity was analyzed using MTS assays at different time points. Compared to non-treated 
cells, metabolic activity was lost in cells treated with 100 μM or 500 μM of 5-FU, while a basal metabolic activity remains in cells treated 
with 10 μM of 5-FU. Graphs present means and SD of at least three independent experiments. *: P < 0.05; **: P < 0.01; ***: P < 0.001.
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mRNA in non-polysomal fractions (NP, including free 
non-translated and poorly translated RNAs) and polysomal 
fractions (P, including actively translated RNAs) (Figures 2C-
2D and Supplementary Figure 2A). First, for every gene, the 
detection of mRNA in non-polysomal (NP) and polysomal 
(P) fractions was assessed in non-treated and 5-FU treated 
cells using DNA microarray. Second, in each condition, the 
relative distribution of a given mRNA between NP and P 
fractions was estimated by calculating the ratio of the probe 
signal obtained for the P fraction to the NP fraction. Third, 
comparison of mRNA distribution between non-treated and 
treated cells was performed by calculating the translational 
index (TI), which represents the variation of the distribution 
of a particular mRNA between NP and P in response to 5-FU 
treatment. Thus, for each mRNA, the TI reflects the fold-
change of its translation efficiency in response to 5-FU.
Figure 2: Impact of 5-FU treatment on protein synthesis in HCT-116 cells. (A-B) Global protein synthesis in response to 
5-FU. Protein synthesis was quantified by 35S labeling pulse-chase assays in non-treated and 5-FU treated cells. A representative gel is 
shown in (A) and mean quantification of three independent experiments is shown in (B). Compared to non-treated cells, a reproducible 
decrease in protein synthesis was observed in response to 10 μM of 5-FU for 24 hrs. Cycloheximide (CHX) was used as a positive 
control. (C-D) Polysome profiles in response to 5-FU. 40S and 60S ribosomal subunits, 80S monosomes and polysomes were separated by 
ultracentrifugation on sucrose gradients. One representative polysome profile of non-treated (C) and 10 µM 5-FU treated cells (D) is shown, 
as well as gel analysis of 18S and 28S rRNA used to verified RNA quality. On top of each profile, the fractions collected for microarray 
analyses (non-polysome NP and polysome P) are indicated. After RNA extraction, RNA quality was checked using bioanalyzer, the RNA 
Integrity Number (RIN) ranging from 6.6 to 9.3.
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Two independent experiments were performed using 
this approach to determine change in TI in 10 µM 5-FU 
treated cells compared to non-treated cells. The probe 
intensities issued from the two biological replicates were 
significantly correlated supporting the robustness of this 
translatome profiling (Supplementary Figures 2B-2E). 
Globally, 12,131 genes were commonly detected in both 
non-treated and treated conditions (Supplementary Figure 
2F). These common genes were used to analyze changes 
in translation efficiency in response to 5-FU by calculating 
the translational index (TI). By applying cut-off values of 
1.5 and P-value < 0.05 to the TI of the 12,131 common 
genes [27], we identified 313 genes (2.6%) whose TI was 
significantly changed in response to 10 µM of 5-FU for 
24 hrs in HCT-116 cells (Figure 3A and Supplementary 
Table 1). These data indicated that 5-FU treatment altered 
translation efficiency of some mRNAs. Among them, 29 
were translationally down-regulated (9%) while 284 were 
up-regulated (91%). The range of TI varied from -1.5 to 
-2.5 and from 1.5 to 2.9 (Figure 3B and Supplementary 
Table 2). In particular, 25 genes displayed a TI above 2, 
indicating that 5-FU treatment induces a 2-fold increase 
in polysome association of some mRNAs (Table 1). Using 
lower or higher cut-off values (TI: 1.3 or 2.0), we observed 
that up-regulation of translation efficiency was always 
much more frequent than down-regulation (Supplementary 
Table 1). Thus, gene-specific modulation of translational 
efficiency in response to 10 µM of 5-FU for 24 hrs in 
HCT-116 cells corresponded mainly to stimulation (for 
genes list see Table 1 and Supplementary Table 2).
Validation was performed by calculating the TI 
of 11 genes, which were selected on the basis of the 
significance and the absolute values of their TI measured 
using microarray. RT-qPCR were performed on HCT-116 
NP and P fractions that were used for microarrays analyses 
(two independent replicates) and from two additional 
independent experiments. Compared to microarray data, 
similar up- and down-regulation of TI were observed in 
the panel of 11 genes analyzed by RT-qPCR (Figure 4A). 
A difference in the range of TI was observed between 
the two methods that can be explained by a difference in 
sensibility of these methods. However, a significant and 
positive correlation was observed between TI obtained 
from RT-qPCR and microarray analyses (Figure 4B). 
Similar analyses using RT-qPCR quantification of mRNA 
distribution within polysome profiles were performed in 
two additional colorectal cancer cells (Figure 4C). We 
used the p53-null HCT-116 cells and the mutant p53.
R273H HT-29 cells (Supplementary Figure 1, IARC 
TP53 Database), to determine whether this translational 
regulation occurs in different colorectal cancer cell 
lines and whether it is dependent of p53 since several 
data support a role of p53 as a regulator of translational 
reprogramming [28]. Like in HCT-116 cells, TI of a panel 
of 7 genes were either reduced or increased in response to 
5-FU in these two cell lines, similarly to what observed 
in HCT-116 cells. Of note only 3 genes in HT-29 did not 
show variation in their TI. Interestingly, since similar 
pattern of TI was observed in wild-type p53 HCT-116 
cells, p53-null HCT-116 cells and mutant p53.R273H HT-
29 cells, it appeared that changes in TI of each mRNA 
revealed by the translatome profiling are independent 
of p53. Altogether, the validation procedure performed 
on different genes in several cell lines confirmed that 
5-FU treatment at 10 µM for 24 hrs reduced or increased 
the association of a subset of mRNAs with polysomes, 
indicating respectively either a reduction or an increase in 
translational efficiency of some mRNAs.
To decipher whether alteration in translational 
efficiency directly resulted from 5-FU treatment or 
from 5-FU-induced change in transcriptional and post-
transcriptional regulation, we quantified the levels of 
total and cytosolic mRNAs in response to 24 hrs of 10 
µM 5-FU treatment in HCT-116 p53-null and HT-29 cells 
(Supplementary Figure 3). No concordance was observed 
between 5-FU-induced transcriptional, post-transcriptional 
and translational variation, as confirmed by correlation 
analyses. These data suggest that 5-FU alters translational 
efficiency independently of any change at mRNA levels. 
Finally, no change in TI analyzed in cytosolic lystates 
was observed in HCT-116 cells treated for 4 hrs by 10 
µM 5-FU while increased in cytosolic mRNA levels 
were observed (Supplementary Figure 4). Once again, 
no concordance between transcriptional and translational 
events was observed at early time point although 5-FU 
affects more rapidly transcriptional regulatory events than 
the translational ones.
Altogether, our data showed that 5-FU treatment at 
10 µM for 24 hrs alters the translatome independently of 
any transcriptional and post-transcriptional regulation of 
the targeted mRNA. In addition, 5-FU mainly increases 
the translation efficiency of a subset of mRNAs.
Genes involved in DNA replication and gene 
expression regulation are selectively regulated by 
5-FU at the translation level
To determine the main functions of genes whose 
recruitment whithin polysomes was altered in response 
to 5-FU in HCT-116 cells, we performed Gene Ontology 
analysis using the Functional annotation clustering 
analytic modules of DAVID bioinformatics resources 
that provides a rank classification of enriched functions 
based on determination of P-values and enrichment 
scores [29]. Statistical enrichment analyses were 
performed separately on genes translationally up- and 
down-regulated, using the lists of 313 (TI cut-off of 
1.5, P < 0.05) and 798 (TI cut-off of 1.3, P < 0.05) 
translationally dysregulated genes. Clusters of functional 
annotation common to both lists are presented in Figure 
5 (for a complete list of functional annotation clustering, 
see Supplementary Table 3).
Oncotarget46224www.impactjournals.com/oncotarget
Using this approach, only one functional cluster 
was identified for the genes whose translation efficiency 
was down-regulated in response to 5-FU treatment. 
This cluster contained 5 of the 29 translationally down-
regulated genes (17%). It was composed of genes involved 
in DNA replication, such as ASF1B or TBCD (Figure 
5 and Supplementary Table 3). These data suggested 
that 5-FU reduced the translation efficiency of mRNAs 
involved in DNA replication.
Genes whose translation efficiency was up-regulated 
by 5-FU clustered into five groups showing enrichment 
scores ranging from 1.7 to 4.9 (Figure 5). The group which 
displayed the most significant P-value and the highest 
enrichment score, contained genes encoding zinc finger 
proteins, including several ZNF family members and 
HIVEP2 (Figure 5 and Supplementary Table 3). These 
proteins are mainly involved in transcription regulation. A 
second cluster closely related to the transcription process 
(cluster 3) was enriched in genes coding proteins with 
B-box domains. These data suggest that 5-FU treatment 
selectively increases the translation efficiency of a subset of 
mRNAs encoding transcriptional regulators. Translationally 
up-regulated genes were also enriched in genes involved 
in translation and translational regulation. Indeed, clusters 
2 and 4 contained genes involved in translation initiation 
and elongation (EIF3F, EIF3E…) and in production of the 
translational machinery, including ribosome components 
(RPL13…) and tRNA maturation factors. Altogether, these 
data showed that genes whose translation efficiency was 
up-regulated in response to 5-FU treatment for 24 hrs were 
mainly involved in regulation of gene expression, including 
transcription and translation.
Figure 3: Effect of 5-FU on translatome of HCT-116 cells. (A) Percentage of translationally deregulated mRNAs in response 
to 5-FU. Among the 12,131 genes commonly detected on the eight Affymetrix exon-arrays (NP-CTL, P-CTL, NP-5-FU, P-5-FU – 
each in duplicates), 2.6% (n=313) were significantly deregulated at translational levels (TI cut-off = 1.5, P < 0.05). Among these 
translationally deregulated genes, 9% were down-regulated and 91% up-regulated. These data were issued from two independent 
experiments. (B) Distribution of the Translational Index (TI). Among the 313 genes significantly deregulated at translational levels, TI 
varies from -2.5 to 2.9. TI of HIVEP2 mRNA is indicated. For list of genes translationally deregulated see Table 1 and Supplementary 
Tables 1 and 2.
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5-FU induces translational up-regulation of 
HIVEP2 mRNA through down-regulation of 
mir-155
To investigate the molecular mechanisms 
contributing to the modulation of translational efficiency 
of specific mRNA in response to 5-FU treatment, we 
focused our attention on HIVEP2 mRNA, one of the most 
translationally deregulated genes (Figure 3B). Indeed, 
our translatome profiling and validation process showed 
that the distribution of HIVEP2 mRNA was significantly 
increased in polysomes compared to non-polysomes in 
response to 5-FU in a panel of three colorectal cancer 
cell lines (Figures 3B, 4A, 4C and 6A). We determined 
whether this change in HIVEP2 mRNA translation was 
paralleled with a change in mRNA and protein levels in 
HCT-116 cells. RT-qPCR analysis showed a significant 
40% decrease of HIVEP2 mRNA levels in both total and 
cytosolic extracts in response to 5-FU treatment (Figure 
6B). In parallel, a significant 1.5-fold increase in HIVEP2 
protein levels was observed in response to 5-FU treatment 
(Figure 6C and Supplementary Figure 5A). These data 
demonstrated that despite the decrease of HIVEP2 mRNA 
levels in response to 5-FU, the selective increase in its 
translational efficiency led to an increase in HIVEP2 
protein levels.
Table 1: List of the 25 most translationally dysregulated genes in response to 10 μM 5-FU in HCT-116 cells.
Gene symbol Translational Index P-value


























Translationally down regulated mRNAs
CDKL4 -2.455 5.84E-05
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miRNAs reduce mRNA translation by direct 
interaction with specific mRNAs that is a pre-requisite 
for subsequent mRNA degradation [30, 31]. HIVEP2 
mRNA was previously identified as a direct target of mir-
155 [32]. We thus wondered whether mir-155 expression 
may be regulated by 5-FU, thereby participating in the 
stimulation of HIVEP2 mRNA translational efficiency. 
In HCT-116 cells, quantification of mir-155 expression 
by RT-qPCR showed a significant reduction of 50% in 
response to 5-FU treatment for 24 hrs (Figure 6D). Thus, 
by decreasing mir-155 expression, 5-FU could counteract 
mir-155-mediated inhibition of HIVEP2 translation and 
thus promote HIVEP2 mRNA translation. Interestingly, 
reduction in mir-155 levels was observed from 4 hrs 
(Supplementary Figure 5B), suggesting a direct effect of 
5-FU on mir-155 expression. To determine the effect of 
mir-155 on HIVEP2 mRNA translation, we performed 
3’UTR luciferase reporter assays using HIVEP2 3’UTR 
reporter. Over-expression of mir-155 in the absence of 
5-FU significantly reduced the Firefly/Renilla luciferase 
activity ratio of the HIVEP2 3’UTR reporter and of the 
positive control BACH1 3’UTR reporter while it had no 
impact on a 3’UTR-less negative control (Supplementary 
Figure 5C) [32]. Using this system, we assessed the role 
of HIVEP2 3’UTR and mir-155 expression in the increase 
in HIVEP2 mRNA translation in response to 5-FU 
treatment (Figure 6E). In the absence of transient mir-155 
over-expression (mir-CTL condition), 5-FU treatment 
Figure 4: Validation of translatome profiling in a panel of colorectal cancer cell lines. (A) Comparison of TI determined by 
Affymetrix exon-array and RT-qPCR in HCT-116 cell line. Validation in HCT-116 cells was performed by calculating the TI of 11 genes 
in response to 24 hrs exposure to 10 μM 5-FU using RT-qPCR on polysome profiles used for DNA microarrays analyses (two replicates) 
and additional, independent fraction preparation (at least two additional replicates). Similar down- and up-regulation were observed. 
(B) Correlation between TI calculated from Affymetrix exon-array and RT-qPCR in HCT-116 cells. Mean TI obtained by microarrays and 
RT-qPCR were plotted and correlation was assessed by Spearman correlation. A significant correlation was observed between Affymetrix 
exon-array and RT-qPCR data. (C) Comparison of TI in a panel of colorectal cancer cell lines in response to 10 μM of 5-FU for 24 hrs. 
TI of 7 genes determined by Affymetrix exon-array in HCT-116 cells (black bars) and determined by RT-qPCR in HCT-116 p53-null cells 
(white bars) and in HT-29 cells (striped bars) were compared. All the 7 genes showed similar translational modulation in both HCT-116 
and HCT-116 p53-null cells. Only 3 genes out of 7 showed no translational dysregulation in HT-29 cells, whereas the 4 other genes showed 
similar translationnally up- and down-regulation in response to 24 hrs of 5-FU exposure in the three cell lines. Graph presents mean and 
SD. TI below cut-off used for microarrays analyses were represented by grey area.
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significantly increased the Firefly/Renilla luciferase 
activity ratio of the HIVEP2 3’UTR reporter. Importantly, 
this increase in luciferase activity was not paralleled 
with a variation in luciferase mRNA levels (Figure 6F). 
These data suggested that increase in luciferase activity 
results from change in translation rather than change in 
transcription of the chimeric Firefly Luciferase – HIVEP2 
3’UTR. Thus, HIVEP2 mRNA translation in response 
to 5-FU treatment was, at least in part, related to the 
3’UTR of HIVEP2 mRNA. In 5-FU treated cells, mir-155 
expression was then restored using an expression vector 
(Figure 6E). Restoration of mir-155 expression reduces 
the induction of Firefly/Renilla luciferase activity ratio 
in 5-FU treated cells. In addition, no significant change 
in the luciferase mRNA levels was observed, indicating 
that restoration of mir-155 in 5-FU treated cells inhibits 
translation without affecting transcriptional expression 
of the luciferase reporter assay (Figure 6F). Interestingly, 
similar reduction in mir-155 expression from 4 hrs post-
treatment and in mir-155-dependent HIVEP2 translation 
in response to 5-FU was observed in p53-null HCT-116 
cells, indicating a p53-independent effect (Supplementary 
Figure 6). Thus, over-expression of mir-155 was sufficient 
to inhibit the increase in HIVEP2 mRNA translation that 
was induced by 5-FU. Altogether, these data showed that 
the alteration of mir-155 in response to 5-FU mediated a 
translational regulation of the HIVEP2 mRNA.
To determine whether mir-155 may have a broader 
role in translational regulation in response to 5-FU 
treatment, we first analyzed the enrichment of mir-155 
target genes among the genes whose translation efficiency 
was altered by 5-FU treatment in HCT-116 cells, using 
a list of 719 experimentally validated mir-155 target 
genes (miRTarBase [33]) (Figure 6G and Supplementary 
Table 4). Interestingly, a significant enrichment in mir-
155 target genes was observed among the translationally 
up-regulated genes (Up) when compared to the whole 
genome (Up vs Microarray, P = 0.0389), while no 
enrichment of mir-155 target genes was found among the 
genes translationally down-regulated by 5-FU (Down vs 
Microarray, P = 0.3088). As shown in Figure 6G, 19 of 
the genes that were translationally up-regulated by 5-FU 
corresponded to mir-155 target genes (6.7%). We validated 
the translationnally up-regulation of a panel of mir-155 
target genes in response to 5-FU in HCT-116 p53-null and 
HT-29 cells. Although the kinetic of mir-155 expression 
in response to 5-FU exhibited opposite variation at 
24 hrs in HT-29 compared to the isogenic HCT-116 
cellular model while this kinetic remained similar at 4 
hrs (Supplementary Figures 5B, 6A and 7), the three cell 
lines showed a comparable tendency to translationally up-
regulation of mir-155 target genes in response to 5-FU 
(Supplementary Figure 8). These data suggest that the 
early down-regulation of mir-155 in response to 5-FU 
treatment may contribute to the increased translation of a 
subset of mRNAs in colorectal cancer cells. Interestingly, 
Gene Ontology analysis of these mir-155 target genes 
whose translation was up-regulated in response to 5-FU 
mainly corresponded to proteins involved in transcription 
(Supplementary Table 5).
Figure 5: Gene ontology analysis of translationally deregulated genes in 5-FU treated HCT-116 cells. GO enrichment 
was determined using the Functional annotation clustering tools from DAVID. Translationally up-regulated genes are mainly involved 
in transcription and translation, while translationally down-regulated genes are involved in DNA replication. Only the 3 first terms were 
shown for all clusters identified (up-regulation: 5 clusters; down-regulation: 1 cluster). For complete data see Supplementary Table 3.
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Figure 6: Translation regulation of HIVEP2 mRNA by mir-155 through its 3’UTR under 5-FU treatment in HCT-116 
cells. (A) Distribution of HIVEP2 mRNA in polysomal and non-polysomal fractions. HIVEP2 mRNA levels was quantified in polysomal 
(mRNA actively translated) and non-polysomal fractions (free and poorly translated mRNA) by RT-qPCR in two additional and independent 
polysome separation. Increase in HIVEP2 mRNA levels was observed in polysome in 5-FU treated HCT-116 cells compared to non-treated 
HCT-116 cells. (B) Variation of HIVEP2 mRNA levels in response to 5-FU in HCT-116 cells. HIVEP2 mRNA levels were quantified 
by RT-qPCR in both total and cytosolic RNA. 5-FU treatment significantly reduces HIVEP2 mRNA levels. (C) Expression of HIVEP2 
protein in response to 5-FU in HCT-116 cells. HIVEP2 protein levels were analyzed by Western blot. 5-FU treatment increases HIVEP2 
protein levels. (D) Expression of mature mir-155 under 5-FU treatment. Mature mir-155 expression levels were quantified by RT-qPCR in 
treated and untreated HCT-116 cells. 5-FU treatment significantly reduces mature mir-155 expression levels. (E-F) Analysis of HIVEP2 
translational regulation through its 3’UTR using luciferase reporter assays. Luciferase activities were measured to determine the role of 
mir-155 on HIVEP2 3’UTR-dependent translation in response to 0 or 10 μM 5-FU for 24 hrs (E). mRNA levels of Firefly and Renilla genes 
were analysed to verify that variation in luciferase activity shown as F-Luc/R-Luc (RLU) is not due to variation of F-Luc/R-Luc at mRNA 
levels (F). (G) Enrichment of mir-155 target genes in translationally dysregulated genes. Statistical analyses showed that mir-155 target 
genes were enriched in translationally up-regulated genes in response to 5-FU. The list of mir-155-target genes translationaly up-regulated 
is given in the box. Graphs present means and SD of at least two independent experiments. *: P < 0.05; **: P < 0.01; ***: P < 0.001.
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DISCUSSION
The anti-metabolite 5-FU has been shown to alter 
gene expression at transcriptional and splicing levels and 
to alter the translation machinery, mainly by affecting the 
processing and functions of rRNA and tRNA [15, 18, 19, 
21, 22]. However, the impact of 5-FU on translational 
control remained unclear. Using translatome profiling, 
we show here for the first time that 5-FU induces a 
translational reprogramming since, while reducing the 
global protein synthesis, 5-FU increases translation of a 
subset of mRNAs, at least in part through miRNA-based 
mechanisms.
As already reported, we identify two kinetics of 
cellular response to 5-FU [7]. While high doses of 5-FU 
exposure result in drastic and rapid cytotoxic effects, 
low doses, which correspond to doses used in the clinic 
[34, 35], promote delay in cytotoxicity. In particular, 
cells exposed to 10 μM of 5-FU for 24 hrs remain 
viable and metabolically active, and keep their capacity 
to synthesize proteins. By comparing mRNA levels in 
polysomal (translated mRNAs) and non-polysomal (free 
and poorly translated mRNAs) fractions using DNA 
microarray [26], we demonstrate that low doses of 5-FU 
specifically alter the translation efficiency of about 300 
mRNAs. Importantly, the validation procedure performed 
on different genes in a panel of three colorectal cancer cell 
lines confirmed that 5-FU treatment alters the association 
of some mRNAs with polysomes. By analyzing the 
abundance of mRNAs in polysomal fractions using 
genome-wide approaches two previous studies have 
suggested that 5-FU affects translation [23, 24]. However, 
since no normalization to non-polysomal fraction or total 
RNA was done in these studies, alteration of translation 
efficiency was not directly addressed in these studies. In 
addition, both studies had potential bias. Indeed, one of 
these studies used colorectal cancer cells with decreased 
or increased expression of thymidylate synthase, a key 
mediator of 5-FU cytotoxicity, thus complicating the 
analysis of the direct impact of 5-FU on translation [7, 
23]. The second study used Hsp70 immunoprecipitation 
to purify ribosomes presenting newly synthesized proteins 
[24]. This approach may suffer from several biases since 
Hsp70 was recently reported to bind RNA, Hsp70 is not 
required for newly synthesized small proteins, and Hsp70 
levels are reduced in response to 5-FU [36-39].
Our data indicate that exposure to 5-FU promotes 
increase in translational efficiency of only a subset of 
mRNAs. It appeared that the 5-FU-induced change 
in translation efficiency obtained in our experimental 
conditions is independent of any transcriptional and post-
transcriptional modulation induced by 5-FU treatment in 
a panel of three colorectal cancer cell lines. Indeed, we 
showed that, although change in translation efficiency 
is not an early event, modulation of translation does not 
correlate with modulation of transcription, as shown for 
several genes including HIVEP2. Change in transcription 
can thus not explain the observed change in translation. 
Several mechanisms can explain the change in translational 
control of only a subset of transcripts in response to 5-FU. 
Such modulation in translational efficiency can result for 
example from 5-FU-induced alteration of expression of 
factors involved in translational control such as proteins or 
miRNAs [2]. Our data showed that 5-FU-induced change 
in translational efficiently occurred independently of the 
p53 protein, a stress sensor known to regulate translation 
through numerous mechanisms [28]. Our data rather 
identified mir-155 as a common regulator of 5-FU-mediated 
alteration of translational efficiency for several target genes.
We indeed showed that reduction of mir-155 
in response to 5-FU can promote HIVEP2 mRNA 
translation in HCT-116 colorectal cancer cells. In addition, 
determination of the molecular mechanism by which 
5-FU regulates HIVEP2 also supports that 5-FU regulates 
translation efficiency. Indeed, cell exposure to low doses 
of 5-FU decreases HIVEP2 mRNA levels in both total 
and cytosolic fractions while in the same time, HIVEP2 
mRNA is concentrated in the actively translated polysomal 
fractions, and HIVEP2 protein levels are increased in 5-FU 
treated cells. Moreover, our data reveal that increased 
translation of HIVEP2 mRNA in response to 5-FU results 
from abolition of mir-155-mediated inhibition of HIVEP2 
mRNA translation. By reducing mir-155 expression, 5-FU 
promotes translation of HIVEP2 mRNA. This observation 
is in accordance with the repressing role of miRNAs, 
which have been shown to inhibit translational regulation 
before inducing mRNA degradation – inhibition, which 
can be removed by reducing miRNA expression [30, 31]. 
Furthermore, we showed and validated that mir-155 target 
genes are enriched in genes translationally up-regulated, 
establishing that reduction in mir-155 levels in response 
to 5-FU could explain about 7% of the translationally 
up-regulated gene. Interestingly, plasmatic mir-155 
expression levels were found to be decreased after 5-FU-
based chemotherapy exposure of colorectal cancer cells’ 
patients [40]. miRNA regulation is likely a more general 
mechanism leading to alteration of translation in response 
to 5-FU, because miRNA profiling identified several 
miRNAs, whose expression is either up- or down-regulated 
in response to 5-FU [12, 14, 41]. However, until now, these 
changes in miRNA expression levels have not been linked 
to alteration of translation. Additional mechanisms remain 
to be explored to explain the translational control of a 
specific subset of mRNAs in response to 5-FU treatment. In 
particular, the impact of 5-FU incorporation into RNAs of 
the translational machinery on translational control remains 
to be investigated.
We show that the selective translation of mRNAs in 
response to 5-FU is accompanied by a decrease in global 
protein synthesis. This reduction in protein synthesis could 
result from the previously described reduction in pre-rRNA 
processing in response to 5-FU since a strict correlation 
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occurs between the rate of ribosome biogenesis and protein 
synthesis [18, 42, 43]. Therefore, the concomitant decrease 
in global protein synthesis and increase in translation of 
a selected subset of mRNAs indicate that 5-FU promotes 
translational reprogramming in colorectal cancer cells.
In conclusion, in the present study we provide a 
novel mechanism, which supports the importance of 
translational control in 5-FU-induced cellular response. 
Overall, our data indicate that low doses of 5-FU promote 
translational reprogramming of colorectal cancer cells. The 
gene-specific stimulation of translation induced by 5-FU 
involves at least in part miRNA-dependent translational 
regulation. However, additional mechanisms remain to 
be investigated in the future. Altogether, our data add to 
the growing body of evidences that support the direct 
contribution of translation in establishing anti-cancer drug 
response as well as potential treatment failures.
MATERIALS AND METHODS
Cell culture
Human colorectal cancer HCT-116 and HT-29 cells 
were obtained from ATCC (CCL-247, HTB-38). Cells were 
maintained in DMEM-glutaMAX supplemented with 10% 
FBS and 1% penicillin/streptomycin (Life technologies) 
at 37°C under 5% CO2 atmosphere. 5-fluorouracil (5-FU) 
was kindly provided by Centre Léon Bérard (purchased at 
Sanofi-Aventis), stored at room temperature at 384 mM in 
sterile water and diluted in cell culture medium.
Cell proliferation and viability
Real-time cell behavior was monitored using 
xCELLigence RTCA system (Roche), which allows 
label-free and dynamic monitoring of cells by measuring 
electrical impedance. 105 cells were seeded in 96 E-plates 
(Roche) 24 hrs prior 5-FU treatments. RTCA system 
displays the measurements of impedance signal as Cell 
Index (CI) values, providing quantitative information about 
the different biological status of the cells including number, 
viability, proliferation and mobility. CI values curves were 
normalized to the time point of 5-FU administration. MTS 
were performed at different time points on 105 cells seeded 
into 96 well-plate 24 hrs prior 5-FU treatments using Cell 
Titer Aqueous One Solution Cell Proliferation assays as 
described by the manufacturer (Promega). Cell viability 
and total cell numbers were quantified in response to 5-FU 
treatment by trypan blue staining method using Cedex XS 
analyzer (Roche) from 150.105 cells seeded in 24 well-
plates 24 hrs prior 5-FU treatment.
Global protein synthesis
Cells were plated 72 hrs before labeling in normal 
medium and treated with 10 µM 5-FU for 24 hrs before 
labeling. Normal medium was replaced with methionine-
cysteine free DMEM for 30 min before labeling. [35S]-
methionine-cysteine was added in the medium at 75 µCi/
mL and cells were incubated for 1 hr at 37°C. Labeling 
was stopped by washing cells with ice cold 1X PBS. 
Cells were scraped in SDS-PAGE laemmli sample buffer, 
and incubated 10 min at 95°C. Fifteen µg of protein was 
loaded onto a 4-20% gradient SDS-PAGE. [35S]-met-cys 
incorporation was quantified using PhosphorImaging on a 
FLA-9500 apparatus (GE). For each labeling experiment, 
protein quantification and SDS-PAGE were performed in 
duplicate.
Preparation of mRNA-associated polysomes
Cells were seeded at 107 cell/15 cm dish and treated 
for 24 hrs with 5-FU. Cells were then incubated for 15 min 
with 100 μg/ml cycloheximide (CHX) and washed twice 
with cold 1X PBS-100 μg/ml CHX before harvesting. 
Cytosolic lysates were prepared in lysis buffer (20 mM 
KCl, 5 mM MgCl2, 50 mM Tris-HCl pH 7.4, 4.5% 
sucrose, 0.5 mM DTE and 100 μg/ml CHX) using dounce 
homogenizer and two successive 10 min centrifugations at 
4°C at 1,000 and 12,000 x g. Ten-40% sucrose gradients 
were prepared using four solutions (10%, 20%, 30% 
and 40% of sucrose dissolved in lysis buffer) that were 
introduced one by one in increased concentration order 
after 30 min at -80°C in Ultra-Clear Tube 9/16 x 3 ½ 
(Beckman). One mg of cytosolic proteins was loaded 
onto a sucrose gradient defrozen overnight at 4°C and 
sedimented by ultra-centrifugation at 40,000 rpm for 2 
hrs at 4°C using SW41 rotor on L7-55 ultracentrifuge 
(Beckman). The gradients were collected in 18 fractions 
and absorbance profiles were generated at 254 nm using 
an ISCO UA-6 detector. RNA quality of the different 
fractions was checked on agarose gel. Non-polysomal 
or polysomal fractions were pooled for further RNA 
extraction using Trizol LS Reagent as described by the 
manufacturer (Life technologies).
Affymetrix exon-array
Quality of RNA purified from polysome 
fractionation was verified using BioAnalyzer (Agilent) 
(RIN ranging from 6.6 to 9.3). 250 ng of total RNA was 
processed with the GeneChip WT Sense Target Labeling 
kit and hybridized to GeneChip Human Exon 1.0 ST 
arrays. Affymetrix exon-array data were normalized with 
quantile normalization. Antigenomic probes were used to 
perform the background correction. Only probes targeting 
exons annotated from full-length cDNA were retained 
for analysis. Cross hybridizing probes and probes with 
lower signals intensity than anti-genomic background 
probes showing the same GC content were removed. Only 
probes with a DABG P-value ≤ 0.05 in at least half of 
the arrays were considered for further statistical analysis. 
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Arrays were performed in two independent replicates. 
The median intensity of all constitutive exonic probes 
was calculated for each gene in each sample, and the 
experimental samples and control groups were compared 
using a Student’s paired t-test. The adopted strategy to 
identify the translationally regulated genes depends on 
calculating the translational index (TI) (Supplementary 
Figure 2A). First the ratios of active mRNAs (polysomal 
fraction P) to inactive mRNAs (non-polysomal fraction 
NP) was calculated for both 5-FU treated and non-
treated cells. Then the translational index (5-FU P/NP)/
(Control P/NP) presents the translational changes for 
each individual transcript. List of genes significantly 
deregulated at translational levels was determined using 
Student’s paired t-test (P < 0.05) and TI cut-off (1.3, 1.5 
or 2) that are classical values used in translatome analyses 
[27]. Gene ontology was performed on gene lists using 
the online DAVID tools using Functional annotation 
clustering analytic modules that performed dedicated 
statistical analysis [29]. The Affymetrix exon-array data 
reported in this article have been deposited in NCBI’s 
Gene Expression Omnibus (GEO) database (accession 
number GSE77180).
Real-time quantitative RT-qPCR
The Affymetrix exon-array was validated by RT-
qPCR using RNA purified from the two polysomal profiles 
used for the exon-array analyses and from four additional 
and independent polysomal profiles. Three criteria have 
been used to select genes for validation: a significant 
difference in mRNA distribution within polysomal and 
non-polysomal fractions between non-treated and 5-FU-
treated cells; a Translational Index (TI) corresponding to the 
highest TI variations; and a mix of translationnally up- and 
down-regulated genes. 250 ng of total RNA were reverse 
transcribed using the M-MLV RT kit and random primers 
(Invitrogen), according to the manufacturer’s instructions. 
Quantitative real-time PCR (qPCR) was carried out using 
the Light cycler 480 II real-time PCR thermocycler (Roche). 
Expression of mRNAs was quantified using LightCycler 480 
SYBR Green I Master Mix (Roche) (Supplementary Table 
6) and normalized using GAPDH expression according to 
the 2-ΔΔCt method. Reverse transcription of miRNAs was 
performed using TaqMan MicroRNA RT kit (no. 4366596, 
Life Technologies). miRNA RT-qPCR was carried out using 
7900HT Fast Real-Time PCR System (Applied Biosystems). 
The expression of mature miR-155 and RNU6B was 
assessed using qPCR primer sets (Life Technologies, cat.no. 
4427975-002623 and 4427975-001093, respectively).
Western blot
Cells were washed in 1X PBS, harvested and total 
proteins were directly extracted in Laemmli buffer (62.5 
mM Tris-HCl pH 6.8, 1% SDS, 0.1 M DTE). Twenty µg 
of total proteins were separated on a 12 % SDS-PAGE and 
transferred on a nitrocellulose membrane using a semi-
dry transfer apparatus. Membranes were saturated with 5% 
milk and incubated with mouse monoclonoal antibodies 
against HIVEP2 (ab70599, AbCam), p53 (DO-1, ab1101, 
AbCam) and Ku80 (ab87860, AbCam). Detection was 
performed with the secondary anti-mouse antibody 
(A4416, Sigma) with Clarity Western ECL substrat kit 
using ChemiDoc Imager (BioRad).
Luciferase reporter assays
500 ng of either miRNA control plasmid (pMSCV-
puro-GFP-mir-CTL) or miR-155 expression vector 
(pMSCV-puro-GFP-mir-155) was co-transfected with 200 
ng of either HIVEP2 reporter plasmid (pMIR-REPORT-
dCMV 3’ UTR HIVEP2) or control reporter plasmid 
(pMIR-REPORT-dCMV) into HCT-116 or HCT-116 
p53-null cells using Lipofectamine reagent (Invitrogen) 
following the manufacturer’s procedure. Firefly luciferase 
activity was used to monitor 3’UTR activity while Renilla 
luciferase activity was used as a control of transfection 
efficiency. 105 cells were seeded 24 hrs prior transfection 
and were treated with 5-FU 24 hrs post-transfection for 
additional 24 hrs before analyzing luciferase activity using 
Dual Reporter Luciferase Assays (Promega). The plasmids 
are a kind gift of Dr. Erik K. Flemington laboratory.
Statistical analyses
Statistical analyses were performed using GraphPad 
Prism 5.0a (GraphPad Software, Inc). Mean comparison 
was performed using Student t-test. Correlation between 
translational index (TI) issued from DNA microarrays 
and RT-qPCR was tested using the non-parametric 
Spearman r test. Enrichment of mir-155 target genes was 
investigated by Chi-square test. All P-values corresponded 
to two-tailed P-values. P-values <0.05 were considered 
statistically significant. Statistical results are given on the 
graphs using conventional annotations: *: P<0.05; **: 
P<0.01; ***: P<0.001.
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